CODEX: Diaphragmatic Ultrasound Associated With RSBI Predict Weaning Issue: the Rapid Shallow Diaphragmatic Index (RSDI)

Sponsor
Centre Hospitalier Régional d'Orléans (Other)
Overall Status
Completed
CT.gov ID
NCT03479047
Collaborator
(none)
100
1
1
9.8
10.2

Study Details

Study Description

Brief Summary

The Rapid Shallow Breathing Index (RSBI) is the ratio between respiratory rate (RR) and tidal volume (VT). It is routinely used to predict mechanical ventilation weaning outcome in ICU patients. However RSBI doesn't reflect the muscular contribution of diaphragm or accessory muscles in generating tidal volume. Actually, diaphragmatic dysfunction can even delay weaning process, because accessory muscles are more fatigable than the diaphragm.

Hence, the investigators hypothesized that diaphragmatic displacement (DD) could be associated with RSBI in a new index named Rapid Shallow Diaphragmatic Index (RSDI) such as: RSDI = RSBI/DD.

The aim of this study is to compare the ability of the RSDI versus the traditional RSBI to predict weaning success in ready-to-wean patients.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: assess diaphragmatic displacement (DD) using ultrasonography
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Mechanical Ventilation Weaning Prediction Improved by Diaphragmatic Ultrasound Associated With the Rapid Shallow Breathing Index
Actual Study Start Date :
Mar 23, 2018
Actual Primary Completion Date :
Jan 16, 2019
Actual Study Completion Date :
Jan 16, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ventilated patients

During a spontaneous breathing trial (SBT) we will simultaneously, for all included patient, assess diaphragmatic displacement (DD) using ultrasonography, respiratory rate (RR) and tidal volume (VT) on ventilator screen.

Diagnostic Test: assess diaphragmatic displacement (DD) using ultrasonography
During a spontaneous breathing trial (SBT) we will simultaneously, for all included patient, assess diaphragmatic displacement (DD) using ultrasonography, respiratory rate (RR) and tidal volume (VT) on ventilator screen.

Outcome Measures

Primary Outcome Measures

  1. Difference between the RSBI area and the RSDI AUC [72 hours post-extubation]

    Difference between the RSBI area under the receiving operator character curve (AUC) and the RSDI AUC in predicting success of mechanical ventilation weaning.

Secondary Outcome Measures

  1. Find a cut-off value for RSDI [72 hours post-extubation]

    - Find a cut-off value for RSDI with the best predicting accuracy for the weaning

  2. Compare traditional RSBI values recorded with scientific publications [72 hours post-extubation]

  3. Find reasons for non-extubation when criteria are gathered [72 hours post-extubation]

  4. Estimate average duration of mechanical ventilation in central nervous system disorder patient [72 hours post-extubation]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥ 18 years

  • Mechanically ventilated patient > 24 hours

  • Weaning ventilator phase (PEEP < 9 cmH2O and Support < 15 cm H2O)

  • Ventilated via tracheostomy tube patient can be included on removal day of the cannula

  • Patient's agreement to participate

Exclusion Criteria:
  • Moribund patient

  • Decision to forgo life sustaining therapy patient

  • Patient with ventilation via tracheostomy tube before admission to ICU

  • BMI > 45

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHR d'Orléans Orléans France 45067

Sponsors and Collaborators

  • Centre Hospitalier Régional d'Orléans

Investigators

  • Principal Investigator: Guillaume FOSSAT, CHR Orléans

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Centre Hospitalier Régional d'Orléans
ClinicalTrials.gov Identifier:
NCT03479047
Other Study ID Numbers:
  • CHRO-2018-02
First Posted:
Mar 27, 2018
Last Update Posted:
May 6, 2019
Last Verified:
May 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Régional d'Orléans

Study Results

No Results Posted as of May 6, 2019